Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2837434
Reference Type
Journal Article
Title
Arginine metabolism in asthma
Author(s)
Scott, JA; Grasemann, H
Year
2014
Is Peer Reviewed?
Yes
Journal
Immunology and Allergy Clinics of North America
ISSN:
0889-8561
EISSN:
1557-8607
Volume
34
Issue
4
Page Numbers
767-775
Language
English
PMID
25282289
DOI
10.1016/j.iac.2014.07.007
Web of Science Id
WOS:000343966200005
Abstract
Nitric oxide (NO) is important in the regulation of airway tone and airway responsiveness. Alterations in the L-arginine metabolism resulting in reduced availability of the substrate L-arginine for NO synthases, as well as the presence of NO synthase inhibitors such as asymmetric dimethylarginine, contribute to the reduced NO formation and airway dysfunction in asthma. Therapeutic interventions aiming to modulate the impaired L-arginine metabolism may help correct the enhanced airway tone and responsiveness in asthma.
Keywords
Arginine metabolism; Nitric oxide synthase; Arginase; Agmatine; Citrulline; Ornithine; Polyamine; ADMA
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity